Kang Choon Lee
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cell death mechanisms and regulation 16
- RNA Interference and Gene Delivery 9
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 13
- Co-authors
- Yu Seok Youn (31 shared papers)Tae Hyung Kim (25 shared papers)Eun Seong Lee (16 shared papers)Seulki Lee (13 shared papers)Kyung Taek Oh (11 shared papers)Patrick P. DeLuca (3 shared papers)Hai Hua Jiang (10 shared papers)Hyeong Jun Byeon (10 shared papers)
- Journals
- Bioconjugate Chemistry (9 papers)Journal of Controlled Release (7 papers)International Journal of Pharmaceutics (7 papers)Biomaterials (7 papers)Archives of Pharmacal Research (3 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Kang Choon Lee
55 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 112
- Pharmaceutical Science 565
- Biomaterials 939
- Molecular Medicine 257
- Endocrinology, Diabetes and Metabolism 288
- Molecular Biology 1.2k
Countries citing papers authored by Kang Choon Lee
This map shows the geographic impact of Kang Choon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Choon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Choon Lee more than expected).
Fields of papers citing papers by Kang Choon Lee
This network shows the impact of papers produced by Kang Choon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Choon Lee. The network helps show where Kang Choon Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Kang Choon Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 267 | |
| 2 | 2011 | 218 | |
| 3 | 2009 | 211 | |
| 4 | 2012 | 161 | |
| 5 | 2014 | 139 | |
| 6 | 2013 | 123 | |
| 7 | 2005 | 109 | |
| 8 | 2010 | 85 | |
| 9 | 2010 | 77 | |
| 10 | 2011 | 71 | |
| 11 | 2015 | 69 | |
| 12 | 2012 | 67 | |
| 13 | 2010 | 64 | |
| 14 | 2005 | 63 | |
| 15 | 2008 | 60 | |
| 16 | 2013 | 59 | |
| 17 | 2019 | 56 | |
| 18 | 2015 | 55 | |
| 19 | 2007 | 53 | |
| 20 | 2011 | 51 |
About Kang Choon Lee
Kang Choon Lee is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (16 papers), Nanoparticle-Based Drug Delivery (13 papers), Advanced Drug Delivery Systems (10 papers), RNA Interference and Gene Delivery (9 papers), Diabetes Treatment and Management (9 papers), Inhalation and Respiratory Drug Delivery (7 papers), Pancreatic function and diabetes (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Pharmaceutical Science (565 citations), Biomaterials (939 citations), Molecular Medicine (257 citations), Endocrinology, Diabetes and Metabolism (288 citations) and Molecular Biology (1.2k citations). Kang Choon Lee has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Yu Seok Youn, Tae Hyung Kim, Eun Seong Lee, Seulki Lee, Kyung Taek Oh, Patrick P. DeLuca, Hai Hua Jiang, Hyeong Jun Byeon, Beom Soo Shin and In‐Soo Kim. Their work appears in journals such as Bioconjugate Chemistry, Journal of Controlled Release, International Journal of Pharmaceutics, Biomaterials and Archives of Pharmacal Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.